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Abstract	
Septins	 are	 guanine	 nucleotide	 binding	 proteins	 that	 are	 conserved	 from	 fungi	 to	
humans.	 Septins	 assemble	 into	 hetero-oligomeric	 complexes	 and	 higher-order	
structures	 with	 key	 roles	 in	 various	 cellular	 functions	 including	 cell	 migration	 and	
division.	 The	 mechanisms	 by	 which	 septins	 assemble	 and	 interact	 with	 other	
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cytoskeletal	elements	like	actin	remain	elusive.	A	powerful	approach	to	address	this	
question	 is	 by	 cell-free	 reconstitution	 of	 purified	 cytoskeletal	 proteins	 combined	
with	fluorescence	microscopy.	Here,	we	describe	procedures	for	the	purification	of	
recombinant	 Drosophila	 and	 human	 septin	 hexamers	 from	 Escherichia	 coli	 and	
reconstitution	 of	 actin-septin	 co-assembly.	 These	 procedures	 can	 be	 used	 to	
compare	assembly	of	Drosophila	and	human	septins	and	their	co-assembly	with	the	
actin	cytoskeleton	by	total	internal	reflection	fluorescence	(TIRF)	microscopy.		
	
INTRODUCTION		
Since	 their	 discovery	 in	 budding	 yeast	more	 than	 forty	 years	 ago	 (Hartwell,	 1971;	
Hartwell,	 Culotti,	 Pringle,	 &	 Reid,	 1974),	 septin	 GTP-binding	 proteins	 have	 been	
shown	 to	be	present	 in	all	 eukaryotes	except	plants	 (Nishihama,	Onishi,	&	Pringle,	
2011;	 Pan,	 Malmberg,	 &	 Momany,	 2007).	 Although	 several	 groups	 encountered	
mammalian	 septin	 genes	 during	 their	 studies	 in	 the	 early	 1990s	 (for	 example,	
(Nakatsuru,	Sudo,	&	Nakamura,	1994)),	the	 identification	and	functional	analysis	of	
Drosophila	 septins	 (Fares,	 Peifer,	 &	 Pringle,	 1995;	 Neufeld	 &	 Rubin,	 1994)	
established	 that	 septin	 family	 proteins	 existed	 in	 animals	 and	 not	 only	 in	 budding	
yeast,	 and	 also	 provided	 strong	 evidence	 for	 roles	 of	 septins	 not	 related	 to	
cytokinesis.	 Soon	 after	 came	 the	 first	 isolation	 of	 native	 septin	 complexes	 from	
Drosophila	embryonic	extracts	using	an	immunoaffinity	approach	(Field	et	al.,	1996),	
which	 provided	 the	 first	 evidence	 that	 septin	 heteromeric	 complexes	 are	 able	 to	
polymerize	 into	 filaments	 in	 vitro.	 This	 study	 was	 followed	 by	 the	 isolation	 of	
endogenous	 heteromeric	 septin	 complexes	 from	 yeast	 extracts	 with	 a	 similar	
immunoaffinity	protocol	(Frazier	et	al.,	1998),	as	well	as	from	mammals,	both	by	rat	
brain	fractionation	(Hsu	et	al.,	1998)	and	by	immunoisolation	from	mouse	brain	and	
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HeLa	cells	(Kinoshita,	Field,	Coughlin,	Straight,	&	Mitchison,	2002).	More	recently,	a	
new	 protocol	 was	 reported	 for	 the	 purification	 of	 endogenous	 septin	 complexes	
from	 Drosophila	 embryonic	 extracts	 with	 a	 fractionation	 approach	 (Huijbregts,	
Svitin,	Stinnett,	Renfrow,	&	Chesnokov,	2009).		
Understanding	the	requirement	and	the	precise	role	of	different	septin	proteins	for	
the	formation	and	stability	of	septin	complexes,	as	well	as	for	their	capacity	to	form	
filaments	necessitated	 the	 co-expression	of	 septins	 in	heterologous	 systems.	 Thus,	
work	 during	 the	 2000s	 focused	 on	 the	 co-expression	 of	 recombinant	 septins	 in	
bacteria	and	in	insect	cells,	using	genetically	encoded	tags	on	one	(in	most	studies)	
or	two	septins	to	facilitate	protein	purification.	Budding	yeast	septin	complexes	were	
purified	from	bacteria	(Bertin	et	al.,	2008;	Farkasovsky,	Herter,	Voss,	&	Wittinghofer,	
2005;	Garcia	et	al.,	2011;	Versele	et	al.,	2004),	mammalian	septin	complexes	were	
isolated	from	bacteria	(Sheffield	et	al.,	2003;	Sirajuddin	et	al.,	2007)	and	insect	cells	
(Kinoshita	 et	 al.,	 2002),	 C.	 elegans	 septin	 complexes	 from	bacteria	 and	 insect	 cells	
(John	 et	 al.,	 2007),	 and	 Drosophila	 septin	 complexes	 were	 also	 expressed	 in	 and	
purified	from	bacteria	(Huijbregts	et	al.,	2009;	Mavrakis	et	al.,	2014)	and	insect	cells	
(Huijbregts	 et	 al.,	 2009).	 Biochemical	 analysis	 and	 electron	 microscopy	 of	 the	
purified	 recombinant	 complexes	 in	 these	 studies,	 as	well	 as	 of	mammalian	 septin	
complexes	 immuno-purified	 (Sellin,	 Sandblad,	 Stenmark,	 &	 Gullberg,	 2011)	 or	
affinity-purified	(Kim,	Froese,	Estey,	&	Trimble,	2011)	from	mammalian	cell	cultures,	
together	 with	 the	 crystal	 structure	 of	 a	 human	 septin	 complex	 (Sirajuddin	 et	 al.,	
2007),	have	altogether	established	that	septins	from	all	organisms	form	rod-shaped	
complexes	 containing	 two,	 three	 or	 four	 septins	with	 each	 present	 in	 two	 copies,	
forming	 a	 tetramer	 (C.elegans),	 hexamer	 (Drosophila	 and	 human)	 or	 octamer	
(budding	yeast	and	human),	respectively.	
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The	combination	of	electron	microscopy	 (EM)	with	 in	vitro	reconstitution	of	septin	
filament	assembly	 in	 low-salt	conditions	(<100	mM	KCl)	using	recombinant	purified	
complexes	has	been	 instrumental	and	 is	still	one	of	the	most	powerful	approaches	
for	 deciphering	 how	 septin	 protomers	 assemble	 into	 filaments	 and	 how	 filaments	
organize	into	higher-order	structures.	The	main	drawback	of	EM	approaches	is	that	
they	 provide	 snapshots	 of	 septin	 organization	 and	 do	 not	 allow	 studies	 on	 how	
freely-diffusing	 septin	 protomers	 dynamically	 assemble,	 grow	 and	 organize	 into	
filament	 assemblies.	 Fluorescence-based	 assays	 using	 purified	 recombinant	 septin	
complexes	present	great	potential	 in	 this	aspect	since	they	can	combine	molecular	
specificity	(when	tagging	specific	septin	subunits)	with	a	wide	range	of	fluorescence-
based	techniques	that	enable	studies	across	different	spatial	and	temporal	scales.		
At	present	there	is	only	a	handful	of	reports	using	fluorescently	tagged	recombinant	
septin	complexes	for	studying	septin	assembly,	almost	exclusively	for	budding	yeast	
septins.	Three	approaches	are	being	used	for	fluorescent	tagging:	(1)	genetic	fusion	
of	 a	 specific	 septin	 subunit	with	 a	 fluorescent	protein,	 such	as	mEGFP	or	mCherry	
(Bridges	 et	 al.,	 2014;	 Sadian	 et	 al.,	 2013),	 (2)	 genetic	 fusion	 of	 a	 specific	 septin	
subunit	with	a	SNAP-tag	and	 its	 further	derivatization	with	 fluorescent	dyes	 (Renz,	
Johnsson,	&	Gronemeyer,	2013),	or	(3)	chemical	conjugation	at	 lysines	or	cysteines	
of	purified	complexes	with	Alexa	Fluor	dyes	(Booth,	Vane,	Dovala,	&	Thorner,	2015;	
Mavrakis	et	al.,	2014).	The	recent	development	of	a	TIRF	imaging	assay	using	purified	
GFP-tagged	yeast	septin	octamers	on	supported	 lipid	bilayers	 (Bridges	et	al.,	2014)	
provided	the	first	fluorescence	microscopy-based	quantitative	assay	for	studying	the	
kinetics	of	yeast	septin	filament	assembly,	highlighting	the	promise	of	this	approach.		
The	 mechanisms	 that	 control	 septin	 assembly	 into	 complexes	 and	 higher-order	
filamentous	structures	and	the	regulation	of	septin	structures	and	their	dynamics	are	
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still	 largely	 unclear.	 Especially	 little	 in	 vitro	 work	 has	 been	 done	 on	 human	 and	
Drosophila	septins,	so	it	remains	unknown	how	animal	septin	assembly	differs	from	
budding	 yeast	 septin	 assembly.	 In	 addition,	 septin	 interactions	 with	 other	
cytoskeletal	 components	 remain	 elusive.	 Here,	 we	 describe	 procedures	 to	 purify	
recombinant	 Drosophila	 and	 human	 septin	 hexamers	 from	 Escherichia	 coli.	 We	
describe	 procedures	 for	 fluorescent	 tagging	 (using	 either	 genetic	 GFP	 fusions	 or	
chemical	 conjugation	 with	 organic	 dyes),	 and	 provide	 protocols	 for	 in	 vitro	
reconstitution	 of	 actin	 and	 septin	 assembly	 in	 surface	 assays	 amenable	 to	 high-
resolution	imaging	by	TIRF	microscopy.		
	
1.	 Cloning	 strategy	 for	 recombinant	 septin	 complex	 production	 in	
bacteria	
To	 isolate	 stoichiometric	 hexameric	 septin	 complexes	 we	 combine	 the	 extended	
pET-MCN	(pET	Multi-Cloning	and	expressioN)	series	as	a	septin	co-expression	system	
(Diebold,	 Fribourg,	 Koch,	 Metzger,	 &	 Romier,	 2011)	 with	 a	 two-tag	 purification	
scheme.	To	this	end,	we	use	two	vectors,	pnEA-vH	and	pnCS.	pnEA-vH	harbors	the	
central	 subunit	of	 the	hexamer	 (DSep1	 for	Drosophila	 septins	or	hSep2	 for	human	
septins)	under	the	control	of	the	T7	promoter,	with	a	TEV-cleavable	6xHis-tag	fused	
to	 its	N-terminus.	pnCS	harbors	the	other	two	septin	genes	(DSep2	and	Peanut	 for	
Drosophila	 septins,	or	hSep6	and	hSep7	 for	human	septins)	under	 the	control	of	a	
single	T7	promoter	(Figure	1).	Using	appropriate	PCR	primers	we	fuse	the	C-terminus	
of	 the	 terminal	 subunit	 of	 the	 hexamer	 (Pnut	 for	 Drosophila	 septins	 or	 hSep7	 for	
human	 septins)	 to	 a	 noncleavable	 eight-amino-acid	 Strep-tag	 II	 (WSHPQFEK,	 1058	
Da).		
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To	 generate	 the	 pnCS	 vector	 harboring	 two	 septin	 genes	 under	 the	 control	 of	 a	
single	 promoter,	 we	 use	 bidirectional	 cloning	 to	 concatenate	 two	 pnCS	 vectors	
encoding	one	 septin	 gene	each.	 Each	 septin	 gene	 in	 the	pnCS	 vector	 is	 flanked	by	
SpeI	on	 the	5'	 side	of	 the	MCS	and	by	XbaI	on	 the	3'	 side.	Using	 standard	 cloning	
procedures	 (Green	 &	 Sambrook,	 2012)	 we	 double-digest	 the	 donor	 plasmid	 with	
SpeI	/	XbaI,	ligate	the	insert	to	SpeI-digested	acceptor	plasmid	and	select	the	clones	
with	the	correct	insert	orientation	using	restriction	analysis	(Figure	1).	
We	 have	 used	 this	 strategy	 for	 successful	 coexpression	 of	 both	 Drosophila	 and	
human	septin	hexamers.	The	flexibility	of	the	pET-MCN	series	(detailed	in	(Diebold	et	
al.,	2011))	enables	rapid	screening	to	test	how	the	position	of	the	tags,	the	order	of	
septin	 genes,	 or	 their	 expression	 under	 a	 single	 or	multiple	 promoters	 affects	 the	
quantity	and	stoichiometry	of	the	resulting	complex.		
	
[Insert	Figure	1	here]	
Figure	1.	Overview	of	cloning	strategy	for	co-expressing	recombinant	septins	using	the	pnEA-vH	and	
pnCS	 vectors	 of	 the	 pET-MCN	 series	 (Diebold	 et	 al.,	 2011).	 Here	 this	 strategy	 is	 used	 for	 the	
generation	of	 recombinant	Drosophila	 (DSep1-DSep2-Pnut)	and	human	 (hSep2-hSep6-hSep7)	 septin	
hexamers.		
	
2.	Expression	of	recombinant	septin	complexes	in	bacteria	
We	 co-express	 His6-hSep2,	 hSep6	 and	 hSep7-Strep	 for	 producing	 human	 septin	
hexamers	 (hSep2-hSep6-hSep7),	 and	 His6-DSep1,	 DSep2	 and	 Pnut-Strep	 for	
producing	Drosophila	septin	hexamers	(DSep1-DSep2-Pnut).	
	
Materials	and	reagents	
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Solutions	are	prepared	in	water	unless	stated	otherwise.	
• plasmids	for	co-expression	of	septins:	
Drosophila	septins:	His6-DSep1	in	pnEA-vH,	DSep2/Pnut-Strep	in	pnCS	
Drosophila	GFP-labeled	septins:	His6-DSep1	in	pnEA-vH,	mEGFP-DSep2/Pnut-Strep	in	
pnCS	
human	septins:	His6-hSep2	in	pnEA-vH,	hSep6/hSep7-Strep	in	pnCS	
• E.coli	BL21(DE3)	competent	cells	(200131,	Agilent	Technologies),	-80°C	
• Ampicillin	(A0166,	Sigma),	100	mg/mL,	-20°C	
• Spectinomycin	(S4014,	Sigma),	100	mg/mL,	-20°C	
• LB	medium	(L3022,	Sigma),	RT	
• LB	agar	(L2897,	Sigma),	RT		
• LB	agar	plates	containing	both	ampicillin	and	spectinomycin	at	100	µg/mL	each,	
4°C	
• SOC	medium	(S1797,	Sigma),	-20°C	
• Terrific	Broth	(091012017,	MP	Biomedicals),	RT	
• IPTG	(EU0008-C,	Euromedex),	1	M,	-20°C		
• 2L	Erlenmeyer	flasks	
	
Day	0.	Heat-shock	transformation	of	bacteria		
We	 use	 standard	 procedures	 (Green	 &	 Sambrook,	 2012)	 to	 co-transform	 E.coli	
BL21(DE3)	 competent	 cells	with	 the	 two	plasmids	encoding	 all	 three	 septin	 genes,	
and	grow	colonies	on	LB	agar	plates	at	37°C	overnight.	
	
Day	1.	Bacterial	pre-culture		
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1.	Using	a	sterile	pipette	tip,	select	a	single	colony	from	your	LB	agar	plate.	Drop	the	
tip	 into	 liquid	 LB	 containing	both	antibiotics	 (1000x	dilution	of	 the	antibiotic	 stock	
solutions)	and	swirl.	Calculate	the	volume	of	the	pre-culture	given	that	you	will	use	
1/50	of	the	total	volume	of	the	culture	for	inoculation.	
2.	Incubate	the	bacterial	culture	at	37°C	for	12-16	h	in	a	shaking	incubator	to	prepare	
your	 pre-culture.	 For	 long-term	 storage	 of	 the	 co-transformed	 bacteria,	 mix	 your	
pre-culture	with	glycerol	to	make	a	50%	v/v	glycerol	stock	and	store	it	at	-80°C.	
	
Day	2.	Bacterial	culture	for	producing	dark	(unlabeled)	septin	complexes	
The	 C-termini	 of	 both	 Peanut	 (when	 co-expressed	with	 DSep1	 and	 DSep2)	 and	 of	
hSep7	 (when	 co-expressed	 with	 hSep2	 and	 hSep6)	 are	 prone	 to	 degradation	 by	
bacterial	proteases	during	protein	expression	(Mavrakis	et	al.,	2014).	The	presence	
of	 the	 Strep-tag	 II	 helps	 isolate	 complexes	 containing	 full-length	 Pnut/hSep7.	 To	
minimize	 degradation,	 we	 developed	 a	 protocol	 whereby	 each	 bacterial	 cell	
produces	 less	 protein	 (short	 induction	 time)	 but	 with	 less	 degradation.	 We	
compensate	 for	 the	 smaller	 protein	 yield	 per	 cell	 by	 using	 Terrific	 Broth	 to	 grow	
bacteria	 at	 37°C	 to	 a	 high	 density	 before	 induction.	We	 typically	 prepare	 6-8	 L	 of	
culture.				
1.	 Add	 700	 mL	 Terrific	 Broth	 containing	 both	 antibiotics	 (1000x	 dilution	 of	 the	
antibiotic	stock	solutions)	into	each	2L	Erlenmeyer	flask.	
2.	Inoculate	each	flask	with	your	pre-culture	(1/50	of	the	culture	volume).		
3.	Incubate	at	37°C	in	a	shaking	incubator	(220rpm)	until	the	OD600	reaches	2-3	(this	
should	take	3h-4h30).	
4.	Induce	protein	expression	by	adding	IPTG	to	0.5	mM	final.	Allow	cells	to	grow	for	3	
h	at	37°C.	
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5.	Collect	cells	by	centrifuging	at	2,800	g	and	4°C	for	10	min.	Pool	bacterial	pellets	in	
a	50	mL	Falcon	tube	and	store	at	-80°C.	If	you	want	to	proceed	directly	with	protein	
purification,	store	the	tube	at	-80°C	for	at	least	30	min,	then	continue	with	cell	lysis.	
	
Days	2-3.	Bacterial	culture	for	producing	GFP-labeled	septin	complexes	
To	minimize	protein	degradation	and	also	allow	GFP	to	fold,	we	grow	cells	at	37°C	to	
a	low	density	and	then	induce	expression	at	17°C	overnight.	We	typically	prepare	8-
10	 L	 of	 culture.	 We	 minimize	 exposure	 to	 light	 by	 covering	 the	 incubator	 with	
aluminum	foil	and	keeping	the	lights	off.	
1.	Inoculate	flasks	with	your	pre-culture	as	described	for	dark	septin	production.	
3.	Incubate	at	37°C	in	a	shaking	incubator	(220rpm)	until	the	OD600	reaches	0.6-0.8	
(this	takes	2h30-3h).	
4.	 Induce	 protein	 expression	 by	 adding	 IPTG	 to	 0.5	mM	 final.	 Allow	 cells	 to	 grow	
overnight	(16	h)	at	17°C.	
5.	 Collect	 and	 store	 bacterial	 pellets	 as	 described	 for	 dark	 septin	 production.	 The	
pellets	should	be	yellow-greenish	confirming	the	presence	of	GFP.	
	
3.	 Purification	 and	 characterization	 of	 recombinant	 septin	 complexes	
from	bacteria	
We	 use	 a	 two-tag	 purification	 scheme	 (His6-tag	 on	 the	 central	 subunit	 i.e.	
DSep1/hSep2	and	a	Strep-tag	II	on	the	terminal	subunit	i.e.	Pnut/hSep7)	in	order	to	
select	 for	 complexes	 with	 full-length	 Pnut/hSep7	 and	 to	 minimize	 isolation	 of	
substoichiometric	 septin	 complexes	 (Figure	 2).	 The	 nickel	 affinity	 column	 isolates	
His6-DSep1/hSep2-containing	 complexes,	 whereas	 the	 Strep-Tactin	 (engineered	
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streptavidin)	 affinity	 column	 further	 isolates	 those	 complexes	 that	 also	 contain	
Pnut/hSep7-Strep	 thus	 heterohexamers.	 A	 final	 gel-filtration	 step	 helps	 remove	
aggregates	 and	 isolate	 hexamers.	We	 use	 the	 same	 protocol	 for	 purifying	 human	
septin	 hexamers	 (hSep2-hSep6-hSep7)	 and	 Drosophila	 septin	 hexamers	 (DSep1-
DSep2-Pnut).	When	purifying	mEGFP-tagged	septins,	we	minimize	exposure	to	light	
by	covering	columns	with	aluminum	foil	and	keeping	lights	off.	
	
[Insert	Figure	2	here]	
Figure	2.	Schematic	overview	of	the	two-tag	purification	scheme	for	 isolating	stoichiometric	human	
septin	 hexamers	 (the	 same	 applies	 to	 Drosophila	 septins	 by	 analogy).	 See	 text	 for	 details.	
Understanding	the	principles	of	septin	complex	assembly	is	an	intense	topic	of	investigation,	and	the	
presence	and	stability	of	intermediate	complexes	has	not	been	fully	documented.	We	show	selected	
populations	 of	 human	 septin	 complexes	 in	 the	 cell	 lysate	 (monomers,	 homo-	 and	 heterodimers,	
heterotrimers	 and	hexamers)	 based	on	 the	 isolation	 and	 characterization	of	 such	 recombinant	 and	
native	complexes	(Kim,	Froese,	Xie,	&	Trimble,	2012;	Mavrakis	et	al.,	2014;	Sellin	et	al.,	2011;	Serrao	
et	 al.,	 2011;	 Sheffield	 et	 al.,	 2003;	 Sirajuddin	 et	 al.,	 2007;	 Sirajuddin,	 Farkasovsky,	 Zent,	 &	
Wittinghofer,	2009;	Zent,	Vetter,	&	Wittinghofer,	2011;	Zent	&	Wittinghofer,	2014).	
	
Materials	and	reagents	
Solutions	are	prepared	in	water	unless	stated	otherwise.	
For	the	lysis	buffer:	
• Tris-HCl	pH	8,	1	M,	RT	
• KCl,	4	M,	RT	
• OmniPur®	Imidazole	(5710-OP,	MERCK	Millipore),	1M,	RT	
• MgCl2	1	M,	RT	
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• PMSF	 (78830,	 Sigma),	 100	 mM	 in	 ethanol,	 -80°C,	 dilute	 into	 lysis	 buffer	
immediately	before	use	
• Lysozyme	(5934-D,	Euromedex),	50	mg/mL,	-20°C		
• cOmplete™	Protease	Inhibitor	Cocktail	Tablets	(11697498001,	Roche),	4°C:	use	1	
tablet	for	50	mL	of	lysis	buffer	
• MgSO4,	2M,	RT	
• DNase	I	(10104159001,	Roche),	2	g/L,	-20°C		
For	protein	purification:	
• d-Desthiobiotin (D1411,	 Sigma),	 powder,	 4°C:	 add	 to	 2.5	mM	 final	 in	 StrepTrap	
elution	buffer	immediately	before	use	
• DTT,	1	M,	-20°C:	add	to	5	mM	final	in	gel	filtration	buffer	immediately	before	use	
• HisTrap	FF	crude	5-mL	column	(17-5286-01,	GE	Healthcare)	
• StrepTrap	HP	1-mL	column	(28-9075-46,	GE	Healthcare)	
• HiLoad	16/600	Superdex	200	pg	column	(28-9893-35,	GE	Healthcare)	
• ÄKTA	FPLC	system	
For	protein	concentration:	
• Amicon	 Ultra	 4	 mL	 Centrifugal	 Filter	 Units	 with	 membrane	 NMWL	 of	 30	 kDa	
(UFC803024,	Millipore)	
• Triton	X-100	5%	v/v,	4°C	
	
Day	1.	Septin	complex	purification	
Filter	all	buffers	through	0.22-µm	filters.	Perform	all	purification	steps	at	4°C.	Keep	
aliquots	from	the	elution	peaks	after	each	purification	step	for	SDS-PAGE/Coomassie	
staining	and	Western	blots	for	monitoring	protein	integrity	and	enrichment	of	septin	
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complexes.	 Measure	 the	 protein	 concentration	 after	 each	 purification	 step	 using	
absorbance	 measurements	 at	 280	 nm	 for	 monitoring	 protein	 loss	 during	 the	
purification	process.	
1.	Resuspend	the	bacterial	pellet	 in	 ice-cold	 lysis	buffer	 (50	mM	Tris-HCl	pH	8,	500	
mM	KCl,	10	mM	imidazole	pH	8,	5	mM	MgCl2,	0.25	mg/mL	lysozyme,	1	mM	PMSF,	
cOmplete™	protease	inhibitor	cocktail,	0.01	g/L	DNase	I,	20	mM	MgSO4).	We	use	100	
mL	of	lysis	buffer	for	a	bacterial	pellet	from	a	6	L	culture.	Lyse	cells	on	ice	with	a	tip	
sonicator	using	5	cycles	of	30	s	"ON",	30	s	"OFF"	(30%	amplitude).	
2.	Clarify	the	lysate	by	centrifugation	at	20,000	g	for	30	min	at	4°C.	
3.	 Load	 the	supernatant	on	a	HisTrap	FF	crude	column	equilibrated	with	5	column	
volumes	(CV)	of	50	mM	Tris-HCl	pH	8,	500	mM	KCl,	10	mM	 imidazole	pH	8,	5	mM	
MgCl2.	Wash	with	7CV	of	the	same	buffer,	then	wash	with	7CV	of	50	mM	Tris-HCl	pH	
8,	 500	 mM	 KCl,	 20	 mM	 imidazole	 pH	 8,	 5	 mM	MgCl2	 to	 remove	 nonspecifically	
bound	untagged	proteins.	
4.	Elute	His6-DSep1/hSep2-containing	complexes	with	7CV	of	50	mM	Tris-HCl	pH	8,	
500	mM	KCl,	250	mM	imidazole	pH	8,	5	mM	MgCl2.	Collect	1-mL	fractions.	Pool	all	
fractions	contained	in	the	elution	peak	(typically	10-15	mL).	
5.	Load	the	pooled	fractions	to	a	StrepTrap	HP	column	equilibrated	with	5CV	of	50	
mM	Tris-HCl	pH	8,	300	mM	KCl,	5	mM	MgCl2.	We	use	two	StrepTrap	HP	columns	in	
tandem.	Wash	with	7CV	of	the	same	buffer.	
6.	Elute	Pnut/hSep7-Strep-containing	complexes	with	7CV	of	50	mM	Tris-HCl	pH	8,	
300	mM	KCl,	 5	mM	MgCl2,	2.5	 mM	 desthiobiotin.	 Collect	 1-mL	 fractions.	 Pool	 all	
fractions	contained	in	the	elution	peak	(typically	5	mL).	
7.	 Load	 the	pooled	 fractions	 to	 a	 Superdex	 200	HiLoad	16/60	 column	equilibrated	
with	1.2	CV	of	50	mM	Tris-HCl	pH	8,	300	mM	KCl,	5	mM	MgCl2,	5	mM	DTT.	Elute	
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with	 1.2	 CV	 of	 the	 same	 buffer.	 Elute	 for	 0.25CV	 before	 collecting	 1-mL	 fractions.	
Pool	 the	 fractions	 corresponding	 to	 the	 elution	 peak	 (typically	 10	 mL)	 and	
concentrate	 using	 passivated	 Amicon	 concentrators	 (see	 below).	 Measure	 the	
concentration	 using	 the	 elution	 buffer	 as	 a	 blank,	 prepare	 10-	 or	 20-µL	 aliquots,	
flash-freeze	 purified	 septin	 complexes	 in	 liquid	 nitrogen	 and	 store	 at	 −80°C.	 This	
purification	protocol	typically	yields	1-2	mg	of	stoichiometric	septin	hexamers,	which	
we	concentrate	to	10-15	µM	(about	3-5	mg/mL).	
	
We	calculate	septin	complex	concentration	from	absorbance	measurements	at	280	
nm.	 We	 compute	 extinction	 coefficients	 from	 the	 amino	 acid	 sequences	 using	
ExPASy	 at	 http://web.expasy.org/protparam/,	 assuming	 two	 copies	 of	 each	 full-
length	septin	(tags	included)	per	hexamer.	
dark	Drosophila	septins (His6-DSep1/DSep2/Pnut-Strep):	
306.9	kDa,	1	g/L	=	3.3	µM,	ε=0.545	L.g-1.cm-1	at	280	nm	(assuming	all	Cys	reduced)	
mEGFP-tagged	Drosophila	septins (His6-DSep1/mEGFP-DSep2/Pnut-Strep):	
361.6	kDa,	1	g/L	=	2.8	µM,	ε=0.584	L.g-1.cm-1	at	280	nm	(assuming	all	Cys	reduced)	
dark	human	septins	(His6-hSEP2/hSEP6/hSEP7-Strep):		
285.7	kDa,	1	g/L	=	3.5	µM,	ε=0.565	L.g-1.cm-1	at	280	nm	(assuming	all	Cys	reduced)	
	
Day	2a.	Concentration	of	purified	septin	complexes	
Septins	tend	to	be	sticky	and	adsorption	to	the	membrane	of	the	concentrator	leads	
to	 significant	 yield	 loss.	 To	 improve	 recovery	 of	 septins	 during	 the	 concentration	
step,	we	passivate	the	concentrators	by	treating	them	with	5%	v/v	Triton	X-100.		
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1.	Wash	 the	 concentrator	 by	 filling	with	water	 and	 spinning	 the	 liquid	 through	 at	
4,500	g	for	10	min.	Remove	residual	water	thoroughly	by	pipetting.	
2.	Fill	the	concentrator	with	5%	v/v	Triton	X-100.	Incubate	for	2	h	at	RT.	
3.	Remove	the	Triton	X-100	solution.	Rinse	the	device	3	or	4	times	thoroughly	with	
water	 and	 finally	 spin	 through	 for	 5	min	 at	 4,500	 g.	 The	 passivated	 device	 is	 now	
ready	to	use.		
4.	 Add	 gel	 filtration	 elution	 buffer	 and	 spin	 through	 for	 5	 min	 at	 4,500	 g	 to	
equilibrate	the	concentrator	membrane.	
5.	 Add	 the	 gel	 filtration	 eluate	 and	 spin	 through	 until	 reaching	 the	 desired	
volume/concentration.	 Do	 cycles	 of	 spinning	 of	 20	min	 at	 4,500	 g.	 Between	 two	
cycles,	check	the	volume	of	the	protein	solution,	refill	with	the	remaining	solution,	
mix	the	protein	solution	very	gently	by	pipetting	up	and	down	and	remove	the	flow	
through.	Keep	an	aliquot	for	SDS-PAGE.	
	
Day	2b.	Characterization	of	purified	septin	complexes	
We	analyze	septin	prep	purity	and	protein	integrity	by	12%	SDS-PAGE	and	Western	
blot.	For	Drosophila	septins,	we	use	mouse	4C9H4	anti-Pnut	(1:100,	Developmental	
Studies	 Hybridoma	 Bank),	 rat	 anti-DSep1-95	 (1:500)	 (Mavrakis	 et	 al.,	 2014)	 and	
guinea	pig	anti-DSep2-92	(1:500)	(Mavrakis	et	al.,	2014).	For	human	septins,	we	use	
goat	 anti-hSep2	 (1:500,	 Santa	 Cruz	 Biotechnology,	 sc-20408),	 rabbit	 anti-hSep6	
(1:500,	Santa	Cruz	Biotechnology,	sc-20180)	and	rabbit	anti-hSep7	(1:200,	Santa	Cruz	
Biotechnology,	 sc-20620).	 For	 both	 Drosophila	 and	 human	 septins,	 we	 use	 HRP-
conjugated	 anti-Penta-His	 (1:10,000,	 Qiagen)	 and	 HRP-conjugated	 anti-Strep-tag	
(1:10,000,	AbD	Serotec).	
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hSep2	 antibodies	 recognize	 the	 N-terminus	 of	 hSep2,	 whereas	 hSep6	 and	 hSep7	
antibodies	 recognize	 the	 C-terminus	 of	 hSep6	 and	 hSep7,	 respectively.	 Pnut	
antibodies	 recognize	 the	 N-terminus	 of	 Peanut	 (Mavrakis	 et	 al.,	 2014),	 whereas	
DSep1-95	and	DSep2-92	antibodies	recognize	the	N-terminus	of	DSep1	and	DSep2,	
respectively	(Mavrakis	et	al.,	2014).	We	combine	these	antibodies	with	the	His-	and	
Strep-tag	 antibodies	 that	 recognize	N-	 and	 C-termini,	 respectively,	 to	 examine	 the	
integrity	of	each	septin	in	the	prep	by	Western	blot.	
The	purity	of	 the	septin	preps	can	be	 further	 tested	by	mass	spectrometry	both	 in	
solution	 and	 from	 protein	 bands	 excised	 from	 the	 gels.	We	 found	 the	 N-terminal	
methionines	of	all	three	Drosophila	septins	cleaved	in	the	bacterial	preps.	The	only	
protein	we	identified	in	our	preps	besides	septins	was	the	bacterial	chaperone	DnaK	
which	runs	at	70	kDa	in	SDS-PAGE	(Mavrakis	et	al.,	2014).		
Finally,	 we	 evaluate	 the	 quality	 of	 each	 septin	 preparation	 in	 terms	 of	 oligomer	
composition	 and	 hexamer	 content	 by	 transmission	 electron	microscopy	 combined	
with	 2D	 single	 particle	 image	 analysis	 (Figure	 3),	 as	 described	 in	 the	 chapter	 by	
Aurelie	Bertin.	
	
4.	Labeling	septins	for	TIRF	imaging		
4a.	Generating	septin-GFP	fusions	
For	TIRF	imaging	of	fluorescent	Drosophila	septins,	fuse	mEGFP	to	the	N-terminus	of	
DSep2	and	generate	a	pnCS	vector	harboring	both	mEGFP-DSep2	and	Pnut-Strep,	as	
detailed	 above.	 Co-express	 His6-DSep1	 with	 mEGFP-DSep2/Pnut-Strep	 to	 produce	
and	 purify	 fluorescent	 septin	 hexamers,	 His6-DSep1/mEGFP-DSep2/Pnut-Strep,	 as	
detailed	above.	
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[Insert	Figure	3	here]	
Figure	 3.	 Characterization	 of	 purified	 septin	 complexes	 by	 SDS-PAGE	 (unlabeled	 and	 GFP-labeled	
Drosophila	septin	hexamers,	left	and	right	panels	in	A,	respectively)	and	by	2D	single	particle	analysis	
of	electron	microscopy	images	(B,	see	chapter	by	Aurelie	Bertin).	
	
4b.	Chemical	labeling	of	purified	septin	complexes	with	Alexa	Fluor	dyes	
Septins	can	be	labeled	at	primary	amines	(ε-amino	group	of	lysines	and	N-terminus)	
using	Alexa	Fluor	488	succinimidyl	esters.	We	isolate	labeled	septins	in	filamentous	
form,	 to	 ensure	 that	 hexamers	 are	 still	 polymerization-competent	 after	 labeling.	
Different	 septin	 complexes	 and	 septins	 from	 different	 species	 can	 polymerize	 to	
different	 extents	 to	 higher-order	 structures	 of	 different	 sizes,	which	might	 require	
optimization	of	the	incubation	and	centrifugation	times	detailed	below.	
	
Materials	and	reagents	
• purified	 septins	 in	50	mM	Tris-HCl	pH	8,	 300	mM	KCl,	 5	mM	MgCl2,	 5	mM	DTT	
(septin	buffer)	
• Alexa	 Fluor	 488	 carboxylic	 acid,	 succinimidyl	 ester	 (NHS	 ester)	 (A20000,	
Invitrogen),	-20°C,	protected	from	light		
• Tris-HCl	pH	8,	1M,	RT		
• Hepes-KOH	pH	8,	1M,	4°C,	stored	in	the	dark	
• PD-10	columns	(GE	Healthcare)	
	
Day	1.	Reaction	with	NHS	ester	and	pelleting	of	polymerization-competent	septins	
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1.	To	exclude	reactivity	of	NHS	esters	with	amine	and	thiol	groups	of	compounds	in	
the	 septin	buffer	 (Tris	and	DTT),	dialyze	 septins	 into	50	mM	Hepes-KOH	pH	8,	300	
mM	KCl,	5	mM	MgCl2.	
2.	Prepare	a	20	mM	stock	of	the	NHS	ester	in	DMSO	immediately	before	starting	the	
reaction.	 Add	 to	 dialyzed	 septins	 at	 4:1	 molar	 ratio	 (dye:septins),	 mix	 gently	 and	
incubate	for	1	h	at	RT	in	the	dark.	Quench	the	reaction	by	adding	Tris	to	20	mM	Tris-
HCl	pH	8	final.	
3.	Add	50	mM	Tris-HCl	pH	8,	5	mM	MgCl2,	5	mM	DTT	to	dilute	KCl	to	50	mM	final	and	
polymerize	septins	for	1	h	at	room	temperature.	To	pellet	polymerization-competent	
Alexa-tagged	septins,	centrifuge	at	100,000	g	for	3	h	at	4°C	(we	use	a	TLA100.3	rotor	
with	 1.5-mL	 tubes).	 The	 resulting	 pellet	 will	 be	 yellow-greenish	 confirming	 the	
reaction	with	Alexa	Fluor	488	(AF488)	NHS	esters.	
4.	 Carefully	 remove	 the	 supernatant	 and	 add	 0.5	mL	 ice-cold	 septin	 buffer	 to	 the	
AF488-septin	pellet.	Allow	the	pellet	to	resuspend	on	ice	overnight	in	the	dark.	Mix	
very	gently	the	next	morning	by	pipetting	up	and	down.	
	
Day	2.	Separation	of	AF488-septins	from	unreacted	AF488	with	a	PD-10	column	
1.	Pre-cool	and	equilibrate	a	PD-10	column	with	25	mL	septin	buffer	and	discard	the	
eluate.	
2.	Add	0.5	mL	of	the	resuspended	AF488-septins.	Once	the	solution	has	entered	the	
column,	add	2.0	mL	septin	buffer.	Discard	the	eluate.	
3.	 Elute	 with	 3.5	 mL	 septin	 buffer	 in	 0.5-mL	 fractions.	 AF488-septins	 elute	 in	
fractions	2-4	(1.5	mL	in	total).	Measure	the	protein	concentration	and	calculate	the	
degree	of	labeling.	Use	the	values	provided	by	the	manufacturer	for	the	dye	(λmax,	ε,	
correction	 factor	 at	 280	 nm)	 to	 correct	 for	 the	 contribution	 of	 the	 dye	 to	 the	
	 18	
absorbance	at	280	nm.	Prepare	10-	or	20-µL	aliquots,	flash-freeze	AF488-septins	 in	
liquid	nitrogen	and	store	at	−80°C	in	the	dark.	
	
5.	Building	flow	cells	for	TIRF	microscopy		
To	visualize	actin	filaments	and	septins	by	total	internal	reflection	fluorescence	(TIRF)	
microscopy,	 we	 design	 flow	 cells	 having	 6	 rectangular	 shaped	 channels	 with	
approximate	dimensions	of	22	mm	in	length,	2.5	mm	in	width	and	0.1	mm	in	height	
(Figure	 4).	 Approximately	 10	 µL	 of	 a	 protein	 solution	 can	 be	 loaded	 into	 each	
channel.			
	
[Insert	Figure	4	here]	
Figure	 4.	 A	 flow	 cell	 assembled	 by	 melting	 strips	 of	 Parafilm	 between	 a	 cleaned	 and	 passivated	
coverslip	and	a	glass	slide.	
	
Materials	and	reagents	
l	H2O2	(35%	in	water,	95299,	Sigma),	4°C	
l	NH4OH	(30%	in	water,	320145,	Sigma),	RT	
l	Dichlorodimethylsilane	(DDS),	(40140,	Sigma),	RT	
l	Trichloroethylene	(TCE),	(251402,	Sigma),	RT	
l	Pluronic®	F-127	(P2443,	Sigma),	10%	in	DMSO,	RT	
To	completely	dissolve	Pluronic®	F-127	powder	in	DMSO,	we	warm	up	the	solution	
to	45°C.	For	flow	cell	treatment,	we	dilute	to	1%	(w/v)	in	F-buffer	right	before	use.			
l	Parafilm	(PM996,	Bemis)	
l	Microscope	glass	slide	(24	×	60	mm,	thickness	#1,	0.15mm,	Menzel	Gläser)	
l	Microscope	coverslips	(22	×	40	mm,	thickness	#1,	0.15mm,	Menzel	Gläser)	
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5a.	Cleaning	and	silanizing	microscope	glass	slides/coverslips	
To	remove	organic	residues	from	the	glass	substrates	of	the	flow	cells,	we	clean	the	
microscope	slides	and	coverslips	in	a	base-piranha	solution.	Additionally,	the	piranha	
treatment	 generates	 free	 hydroxyl	 groups	 on	 the	 glass	 substrates,	 making	 them	
hydrophilic.	To	prevent	nonspecific	protein	adhesion	to	the	surfaces,	we	coat	them	
with	a	hydrophobic	layer	of	dimethylsilane.	
1. Load	microscope	glass	slides	and	coverslips	into	a	Teflon	rack.	
2. Place	the	Teflon	rack	into	a	glass	beaker	filled	with	Milli-Q	water.	Rinse	the	glass	
slides	and	coverslips	twice,	5	min	each,	with	Milli-Q	water	in	a	bath	sonicator.	
3. Transfer	the	Teflon	rack	to	a	new	glass	beaker.	The	glass	beaker	should	be	 large	
enough	to	cover	the	glass	slides	and	coverslips	with	the	base-piranha	solution	(Milli-
Q	water,	30%	NH4OH	and	35%	H2O2	at	a	5:1:1	volume	ratio).	In	a	fume	hood,	fill	the	
glass	beaker	with	five	parts	Milli-Q	water,	heat	on	a	hot	plate	to	80°C.	Add	one	part	
NH4OH	and	 then	slowly	add	one	part	H2O2.	Gently	mix	 the	 solution	by	moving	 the	
Teflon	 rack	 up-and-down	 in	 the	 beaker.	 Once	 the	 piranha	 solution	 reaches	 a	
temperature	 of	 60°C,	 bubbles	 form	 in	 the	 solution,	 indicating	 an	 active	 reaction.	
Allow	the	solution	to	react	for	30	min.		
Tip:	 The	 base-piranha	 solution	 is	 a	 dangerous	 reaction,	 thus	 wear	 gloves	 and	
safety	goggles,	and	avoid	spills.		
Tip:	 Make	 fresh	 base-piranha	 solution	 for	 each	 use	 because	 the	 solution	
decomposes.	The	used	solution	can	be	left	in	the	hood	overnight.	Once	the	reaction	
has	completed,	only	water	is	left,	which	can	be	safely	discarded	down	the	sink.	
4. Rinse	the	slides	and	coverslips	as	in	step	2.	
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5. To	activate	 the	hydroxyl	groups	on	glass	 substrates	 for	 the	 silanization	 reaction,	
transfer	 the	slides	and	coverslips	 to	a	glass	beaker	 filled	with	a	0.1M	KOH	solution	
and	sonicate	for	15	min	in	a	bath	sonicator.		
Note:	If	need	be,	the	substrates	can	be	stored	in	the	0.1M	KOH	solution	for	up	to	one	
month,	otherwise	we	proceed	to	the	following	steps.	
6. Transfer	 the	 slides	 and	 coverslips	 to	 a	 glass	 beaker	 filled	 with	 Milli-Q	 water,	
sonicate	for	5	min,	blow-dry	completely	with	nitrogen	gas,	and	silanize	immediately.	
7. In	a	fume	hood,	prepare	a	solution	of	0.05%	v/v	DDS	in	TCE	in	a	glass	beaker	that	
is	large	enough	to	cover	the	slides	and	coverslips	with	the	solution.	
Note:	Both	DDS	and	TCE	are	volatile	and	toxic,	thus	wear	gloves,	do	not	inhale	and	
work	always	in	the	fume	hood.	
8. Transfer	 the	 slides	 and	 coverslips	 into	 the	 glass	 beaker	 filled	with	 the	 DDS/TCE	
solution	and	incubate	for	1	h,	without	stirring.	
Note:	Carefully	dispose	used	DDS/TCE	 solution	according	 to	 local	 laboratory	 safety	
regulations.	
9. Transfer	 the	 slides	 and	 coverslips	 in	 a	 glass	 beaker	 filled	 with	 methanol	 and	
sonicate	for	15	min	in	a	bath	sonicator.	
10. Blow-dry	 completely	 the	 slides	 and	 coverslips	with	nitrogen	 gas	 and	 store	 in	 a	
clean	sealed	container	for	up	to	one	week.	
	
5b.	Constructing	flow	cells	
Here	we	describe	how	to	construct	a	flow	cell	by	melting	strips	of	Parafilm	between	
a	glass	slide	and	a	coverslip.		
1. Blow-dry	a	silanized	glass	slide	with	nitrogen	gas.	
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2. Cut	 a	 piece	 of	 Parafilm	 that	 is	 large	 enough	 to	 cover	 the	 glass	 slide.	 Place	 the	
Parafilm	layer	on	the	glass	slide	and	press	firmly	to	ensure	the	layer	adheres	to	the	
glass	slide.	The	thickness	of	the	Parafilm	layer	sets	the	height	of	the	flow	channels.		
3. Use	a	scalpel	to	cut	the	Parafilm	layer	along	the	edges	of	the	glass	slide,	trimming	
away	excess	Parafilm	along	the	edges.		
4. Use	a	scalpel	to	cut	2.5	mm	wide	strips	of	the	Parafilm	layer	along	the	short	edge	
of	the	glass	slide.	Cut	11	strips,	centered	with	respect	to	the	glass	slide.	Cut	firmly	to	
ensure	the	edges	of	the	adjacent	strips	are	well	separated.		
5. Remove	every	 second	 strip	by	using	a	 forceps.	 The	width	of	 the	 removed	 strips	
sets	the	width	of	the	flow	channels.		
6. Place	a	silanized	glass	coverslip	on	top	of	the	strips,	centered	with	respect	to	the	
glass	slide.	
7. Place	 the	 assembly	 on	 a	 hot	 plate	 set	 at	 120°C.	 Once	 the	 Parafilm	 strips	 are	
melted,	use	a	 forceps	and	gently	press	 the	coverslip	 to	maximize	 the	contact	area	
between	the	strips	and	the	coverslip.	Do	not	apply	too	much	pressure	that	can	break	
the	coverslip.	Remove	the	assembly	from	the	hot	plate	and	leave	it	to	cool	at	room	
temperature.	
Tip:	 While	 melting	 the	 assembly,	 air	 bubbles	 can	 appear	 at	 the	 contact	 surface	
between	 the	 Parafilm	 strips	 and	 the	 glass	 coverslip.	 Apply	 gentle	 pressure	 on	 the	
coverslip	 with	 a	 forceps	 to	 remove	 the	 air	 bubbles,	 which	 could	 cause	 leakage	
between	adjacent	channels.	
8. Flow	1%	Pluronic®	F-127	into	channels,	incubate	for	5	min	and	rinse	with	the	actin	
polymerization	buffer	(F-buffer)	(see	section	6b	for	the	composition	of	F-buffer).	The	
flow	cell	is	ready	to	use.	
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Note:	 Silanized	 glass	 substrates	 are	 hydrophobic,	which	 hampers	 inflow	of	 sample	
solutions.	 We	 thus	 treat	 channels	 with	 Pluronic	 F-127	 to	 render	 the	 surface	
hydrophilic	enough	to	be	able	to	flow	in	the	aqueous	solution.	
Note:	 Pluronic®	 F-127	 is	 a	 copolymer	 composed	 of	 a	 hydrophobic	 block	 of	
polypropylene	glycol	 flanked	by	two	hydrophilic	blocks	of	polyethylene	glycol,	 thus	
having	surfactant	properties.		
	
6.	In	vitro	reconstitution	of	actin-septin	filament	assembly		
Materials	and	reagents	
Solutions	are	prepared	in	water	unless	stated	otherwise.	
l	DTT	(D0632,	Sigma),	1M,	-20°C	
l	MgATP,	100	mM,	-80°C	
Note:	 To	obtain	MgATP,	prepare	a	200	mM	solution	of	Na2ATP	 (ATP	disodium	salt	
hydrate,	A2383,	Sigma)	by	dissolving	Na2ATP	powder	in	Milli-Q	water	and	adjusting	
the	pH	of	the	solution	to	pH	7.4	using	NaOH	solution.	Mix	the	Na2ATP	solution	1:1	
with	a	200	mM	solution	of	MgCl2	to	obtain	100	mM	MgATP.				
l	Methylcellulose	(M0512,	Sigma),	1%	(w/v),	RT	
l	Protocatechuate	 acid	 (PCA)	 (03930590-50MG,	 Sigma),	 100	 mM	 in	 water	 and	
adjusted	to	pH	9	using	NaOH,	-80°C	
l	Protocatechuate	 3,4-dioxygenase	 (PCD)	 (P8279-25UN,	 Sigma),	 5	µM	 in	 50%	 v/v	
glycerol,	50	mM	KCl,	100	mM	Tris-HCl	pH	8,	-80°C	
l	Trolox	(238813-1G,	Sigma),	100	mM,	-20°C	
To	prepare	a	100	mM	Trolox	solution:	
1. Dissolve	0.1	g	of	Trolox	powder	in	430	µL	methanol	
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2. Add	3.2	mL	of	Milli-Q	water	
3. Add	360	µL	of	1	M	NaOH	(The	solution	turns	yellowish)		
l	VALAP	(a	mixture	of	vaseline,	lanolin	and	paraffin	with	equal	weight),	RT	
	
6a.	Preparing	protein	solutions		
G-actin	 is	purified	 from	rabbit	 skeletal	muscle	by	a	 standard	procedure	 including	a	
final	gel	filtration	step	on	a	HiPrep	26/60	Sephacryl	S-200	HR	column	(GE	Healthcare)	
(Pardee	&	Spudich,	1982).	G-actin	 is	 stored	at	 -80°C	 in	G-buffer	 (2mM	Tris-HCl,	pH	
7.8,	0.2	mM	Na2ATP,	0.2	mM	CaCl2,	and	2	mM	DTT).	G-actin	is	fluorescently	labeled	
with	Alexa	 Fluor®	594	 carboxylic	 acid,	 succinimidyl	 ester	 (AF594-G-actin)	 (Soares	 e	
Silva	et	al.,	2011)	and	is	also	stored	at	-80°C	in	G-buffer.	Dark	and	fluorescent	septins	
are	 stored	 in	 septin	 buffer	 as	 detailed	 above.	 Before	 use,	 aliquots	 of	 actin	 and	
septins	are	thawed	on	ice	and	cleared	for	5	min	at	120,000	g	at	room	temperature	in	
a	Beckman	airfuge.	Finally,	protein	concentrations	are	determined	by	measuring	the	
absorbance	of	the	protein	solutions	at	280	nm,	using	an	extinction	coefficient	of	1.1	
L.g-1.cm-1	for	G-actin	(1	g/L	=	23.8	µM).	Proteins	are	kept	on	ice	and	used	within	one	
week.		
	
6b.	Buffers	and	components	
The	 final	 assay	 buffer	 (referred	 to	 as	 F-buffer,	 or	 actin	 polymerization	 buffer)	
contains	the	following	components:	
l	20	mM	imidazole-HCl,	pH	7.4	
l	50	mM	KCl	
l	2	mM	MgCl2	
l	0.1	mM	MgATP	
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l	1	mM	DTT	
l	1	mM	Trolox	
l	2	mM	PCA	
l	0.1 µM	PCD	
l	0.1%	(w/v)	methylcellulose	
Note:	When	mixing	proteins	with	the	above	components	to	reach	the	composition	of	
the	F-buffer,	take	into	consideration	that	the	septin	buffer	contains	300	mM	KCl	and	
5	mM	MgCl2.	
Note:	Trolox	is	included	in	the	solution	to	quench	triplet	states	and	thus	to	prevent	
photobleaching	due	 to	 the	 reactions	of	 the	 triplet	 states	with	oxygen	 free	 radicals	
(Cordes,	 Vogelsang,	 &	 Tinnefeld,	 2009).	 PCA-PCD	 is	 a	 substrate-enzyme	 pair	 that	
scavenges	oxygen	free	radicals	and	thus	minimizes	photobleaching	 (Shi,	Lim,	&	Ha,	
2010).		
Note:	For	TIRF	 imaging,	we	employ	a	0.1%	(w/v)	solution	of	methylcellulose,	which	
exerts	 an	 entropic	 force	 pushing	 actin-septin	 filaments	 towards	 the	 surface	 to	
facilitate	observation	by	TIRF	imaging.	However,	we	recommend	to	use	at	most	0.2%	
(w/v)	 methylcellulose,	 since	 higher	 methylcellulose	 concentrations	 induce	 the	
formation	of	actin	bundles	(Popp,	Yamamoto,	Iwasa,	&	Maeda,	2006).	
	
6c.	Reconstituting	actin-septin	filament	assembly		
Here	 we	 describe	 a	 procedure	 to	 prepare	 samples	 in	 which	 actin	 and	 septins	 co-
polymerize.	 To	 visualize	 actin	 and	 septins,	we	dope	actin	with	AF594-G-actin	 (10%	
molar	 label	 ratio)	 and	 septins	with	AF488-septins	 or	GFP-septins	 (10%	molar	 label	
ratio)	 (Figure	 5).	 We	 prepare	 protein	 samples	 with	 a	 final	 volume	 of	 10 µl.	 We	
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provide	as	an	example	the	sample	preparation	for	co-polymerizing	1	µM	actin	with	1	
µM	septins.	
	
1. Prepare	 a	 “master	 buffer”	 containing	 5-fold	 higher	 concentrations	 of	 all	 the	
components	of	F-buffer	apart	from	PCD,	taking	into	account	the	contribution	of	KCl	
and	MgCl2	from	the	septin	solution	that	will	be	added	into	the	final	mixture	to	reach	
the	desired	septin	concentration.	
2. Mix	 labeled	 and	 unlabeled	 G-actin	 to	 a	 final	 concentration	 of	 5 µM	 in	 G-buffer	
with	a	10%	molar	label	ratio.		
Note:	Given	that	dense	G-actin	solutions	(>=	5	mg/ml)	are	quite	viscous	and	difficult	
to	mix,	we	dilute	G-actin	to	an	intermediate	concentration.		
3. Mix	labeled	and	unlabeled	septins	to	a	final	concentration	of	6 µM	in	septin	buffer	
with	a	10%	molar	label	ratio.		
4. In	one	Eppendorf	tube,	add	4.1	µL	of	Milli-Q	water,	2	µL	of	master	buffer	(5x),	0.2	
µL	of	PCD	and	1.7	µL	of	labeled	septins	and	mix	well.	
Tip:	We	 typically	dilute	 the	septin	 solution	6-fold	 into	 the	 final	mixture	 in	order	 to	
obtain	50	mM	KCl	 from	the	septin	buffer.	When	performing	a	 series	of	 samples	 in	
which	 actin	 concentration	 stays	 constant	 but	 septin	 concentration	 varies,	 one	 can	
prepare	 septin	 solutions	having	6-fold	higher	 concentrations	 than	 the	 final	desired	
concentrations	by	diluting	septins	 in	septin	buffer,	and	thus	pipette	1.7	µL	of	each	
septin	dilution	in	every	sample.		
5. In	another	Eppendorf	tube,	place	2	µL	of	labeled	actin.	
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6. Load	the	septin	mixture	from	step	4	into	the	G-actin	containing	tube,	mix	the	two	
solutions	 thoroughly	by	aspirating	up	and	down	3	 times	and	 immediately	 load	 the	
mixed	solution	into	one	flow	channel.		
Note:	 Given	 that	 G-actin	 polymerizes	 into	 F-actin	 immediately	 when	 mixed	 with	
salts,	it	is	important	to	perform	the	above	step	quickly.		
7. Seal	 the	 two	 open	 ends	 of	 the	 channels	 with	 VALAP	 using	 a	 cotton-tipped	
applicator.		
Note:	Before	use,	melt	VALAP	at	temperatures	exceeding	80°C.	We	typically	keep	a	
small	beaker	with	liquid	VALAP	on	a	hot	plate	(120°C).	
8. Incubate	the	samples	for	at	least	1	hour	at	room	temperature	to	ensure	complete	
actin	polymerization	before	observation.		
	
To	prepare	septin	 filaments	 in	 the	absence	of	actin	 (Figure	6),	we	 follow	the	same	
procedure	as	above,	but	replace	the	G-actin	solution	with	G-buffer.	
	
For	 experiments	 with	 preformed	 actin	 filaments	 at	 1 µM,	 we	 first	 pre-polymerize	
actin	 at	 24 µM	 (10%	 molar	 label	 ratio)	 in	 F-buffer	 for	 at	 least	 1	 hour	 at	 room	
temperature	in	the	dark.	We	then	follow	the	same	procedure	as	above,	but	prepare	
the	master	 buffer	 by	 taking	 into	 account	 that	 pre-polymerized	 F-actin	 contains	 50	
mM	KCl	and	2	mM	MgCl2.	
	
[Insert	Figure	5	here]	
Figure	 5.	 TIRF	 images	 of	 in	 vitro	 reconstituted	 actin-septin	 co-assembly,	 showing	 AF594-actin	with	
10%	molar	 label	 ratio	 (left),	 AF488-Drosophila	 septins	with	 10%	molar	 label	 ratio	 (middle)	 and	 the	
composite	 image	 (right).	 The	concentrations	of	actin	and	Drosophila	 septins	are	1	µM	and	0.1	µM,	
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respectively.	Under	these	conditions,	the	septins	are	predominantly	present	as	hexamers	(Mavrakis	et	
al.,	2014).	Scale	bar,	10	µm.			
	
[Insert	Figure	6	here]	
Figure	6.	TIRF	images	of	AF488-Drosophila	septin	bundles	at	1	µM	(A)	and	of	GFP-tagged	Drosophila	
septin	 bundles	 at	 1	 µM	 (B).	 The	 spotty	 appearance	 of	 AF488-labeled	 bundles	 suggests	 that	 the	
effective	labelling	stoichiometry	is	below	the	nominal	ratio	of	10%.	Scale	bars,	10	µm.		
	
7.	TIRF	microscopy		
We	 image	 actin-septin	 filament	 assembly	 near	 the	 surface	 of	 the	 passivated	
coverslips	 by	 TIRF	 microscopy,	 which	 is	 ideally	 suited	 to	 provide	 a	 high	 signal-to-
noise	ratio	for	 in	vitro	surface	assays.	Samples	are	 imaged	with	a	Nikon	Apo	TIRF	×	
100/1.49	NA	oil	objective	mounted	on	an	Eclipse	Ti	microscope	(Nikon)	using	491	nm	
and	 561	 nm	 laser	 lines	 and	 imaged	 with	 a	 QuantEM	 512SC	 EMCCD	 camera	
(Photometrics).	We	 generally	 use	 exposure	 times	 of	 100-200	ms	 and	optimize	 the	
laser	power	of	 the	488	nm	and	561	nm	 laser	 lines	 to	maximize	 the	 signal-to-noise	
ratio	while	minimizing	photodamage	(evident	from	the	occurence	of	severing)	of	the	
actin	and	septin	filaments.		
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Figure	legends	
Figure	1.	Overview	of	cloning	strategy	for	co-expressing	recombinant	septins	using	the	pnEA-vH	and	
pnCS	 vectors	 of	 the	 pET-MCN	 series	 (Diebold	 et	 al.,	 2011).	 Here	 this	 strategy	 is	 used	 for	 the	
generation	of	 recombinant	Drosophila	 (DSep1-DSep2-Pnut)	and	human	 (hSep2-hSep6-hSep7)	 septin	
hexamers.	See	text	for	details.		
Figure	2.	Schematic	overview	of	the	two-tag	purification	scheme	for	 isolating	stoichiometric	human	
septin	 hexamers	 (the	 same	 applies	 to	 Drosophila	 septins	 by	 analogy).	 See	 text	 for	 details.	
Understanding	the	principles	of	septin	complex	assembly	is	an	intense	topic	of	investigation,	and	the	
presence	and	stability	of	intermediate	complexes	has	not	been	fully	documented.	We	show	selected	
populations	 of	 human	 septin	 complexes	 in	 the	 cell	 lysate	 (monomers,	 homo-	 and	 heterodimers,	
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heterotrimers	 and	hexamers)	 based	on	 the	 isolation	 and	 characterization	of	 such	 recombinant	 and	
native	 complexes	 (Kim	 et	 al.,	 2012;	 Mavrakis	 et	 al.,	 2014;	 Sellin	 et	 al.,	 2011;	 Serrao	 et	 al.,	 2011;	
Sheffield	 et	 al.,	 2003;	 Sirajuddin	 et	 al.,	 2007;	 Sirajuddin	 et	 al.,	 2009;	 Zent	 et	 al.,	 2011;	 Zent	 &	
Wittinghofer,	2014).	
Figure	 3.	 Characterization	 of	 purified	 septin	 complexes	 by	 SDS-PAGE	 (unlabeled	 and	 GFP-labeled	
Drosophila	septin	hexamers,	left	and	right	panels	in	A,	respectively)	and	by	2D	single	particle	analysis	
of	electron	microscopy	images	(B,	see	chapter	by	Aurelie	Bertin).	
Figure	4.	A	flow	cell	assembled	by	melting	strips	of	Parafilm	between	a	coverslip	and	a	glass	slide.	
Figure	5.	TIRF	 images	of	 in	vitro	 reconstituted	actin-septin	co-assembly.	The	concentrations	of	actin	
and	Drosophila	septins	are	1	µM	and	0.1	µM,	respectively.	Scale	bar,	10	µm.			
Figure	6.	TIRF	images	of	AF488-Drosophila	septin	bundles	at	1	µM	(A)	and	of	GFP-tagged	Drosophila	
septin	bundles	at	1	µM	(B).	Scale	bars,	10	µm.		
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